-
Increased fetal nuchal translucency: possible association with esophageal atresia.
Brown RN, Nicolaides KH.
Ultrasound Obstet Gynecol 2000;15:531-2. -
Maternal age and gestation-specific risk for trisomy 21.
Snijders RJ, Sundberg K, Holzgreve W, Henry G, Nicolaides KH.
Ultrasound Obstet Gynecol 1999;13:167-70. -
First-trimester determination of fetal gender by ultrasound.
Efrat Z, Akinfenwa Y, Nicolaides KH.
Ultrasound Obstet Gynecol 1999;13:305-7. -
Maternal serum S100 protein in normal and Down syndrome pregnancies.
Abraha HD, Noble PL, Nicolaides KH, Sherwood RA.
Prenat Diagn 1999;19:334-6. -
Collagen type VI gene expression in the skin of trisomy 21 fetuses.
von Kaisenberg CS, Brand-Saberi B, Christ B, Vallian S, Farzaneh F, Nicolaides KH.
Obstet Gynecol 1998;91:319-23. -
UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10-14 weeks of gestation.
Snijders RJ, Noble P, Sebire N, Souka A, Nicolaides KH.
Lancet 1998;352:343-6. -
Cerebellar hypoplasia, facial dysmorphism and internal abnormalities: a new recessive syndrome?
Seller MJ, Pal K, Moscoso G, Nicolaides K, Hyett JA.
Clin Dysmorphol 1998;7:41-4. -
Perinatal lung function measurements and prediction of respiratory problems in infancy.
Greenough A, Naik S, Itakura Y, Yuksel B, Cheeseman P, Nicolaides KH.
Physiol Meas 1998;19:421-6. -
First trimester urine free beta hCG, beta core, and total oestriol in pregnancies affected by Down's syndrome: implications for first-trimester screening with nuchal translucency and serum free beta hCG.
Spencer K, Noble P, Snijders RJ, Nicolaides KH.
Prenat Diagn 1997;17:525-38. -
Maternal serum inhibin-A and free beta-hCG concentrations in trisomy 21 pregnancies at 10-14 weeks of gestation.
Noble PL, Wallace EM, Snijders RJ, Groome NP, Nicolaides KH.
BJOG 1997;104:367-71. -
Down's syndrome screening with nuchal translucency.
Nicolaides KH, Sebire NJ, Snijders RJ.
Lancet 1997;349:438. -
Prenatal diagnosis of an extensive fetal lymphangioma using ultrasonography, magnetic resonance imaging and cytology.
Kaminopetros P, Jauniaux E, Kane P, Weston M, Nicolaides KH, Campbell DJ.
Br J Radiol 1997;70:750-3. -
Ultrasound screening for congenital uterine anomalies.
Jurkovic D, Gruboeck K, Tailor A, Nicolaides KH.
BJOG 1997;104:1320-1. -
Ultrasound screening for anencephaly at 10-14 of gestation.
Johnson SP, Sebire NJ, Snijders RJM, Tunkel S, Nicolaides KH.
Ultrasound Obstet Gynecol 1997;9:14-6. -
Screening for trisomy 21 in twin pregnancies by maternal age and fetal nuchal translucency thickness at 10-14 weeks of gestation.
Sebire NJ, Snijders RJM, Hughes K, Sepulveda W, Nicolaides KH.
BJOG 1996;103:999-1003. -
Down's syndrome screeening in the UK.
Nicolaides KH, Sebire NJ, Snijders RJ, Johnson S, Reynolds TM.
Lancet 1996;347:906-7. -
Intrauterine lethality of trisomy 21 fetuses with increased nuchal translucency.
Hyett JH, Sebire NJ, Snijders RJM, Nicolaides KH.
Ultrasound Obstet Gynecol 1996;7:101-3. -
Evolution of sonographic findings in a fetus with agenesis of the urethra, vagina and rectum.
Carroll SG, Hyett J, Eustace D, Seller MJ, Nicolaides KH.
Prenat Diagn 1996;16:931-3. -
Prenatal diagnosis of triosephosphate isomerase deficiency.
Arya R, Lalloz MR, Nicolaides KH, Bellingham AJ, Layton DM.
Blood 1996;87:4507-9. -
Natural history of trisomy 21 Fetuses with fetal nuchal translucency.
Pandya PP, Snijders RJM, Johnson S, Nicolaides KH.
Ultrasound Obstet Gynecol 1995;5:381-3.